Compared to technologies like carbon filtration or ion
exchange, the BioLargo AEC produces far less PFAS-laden waste during the PFAS
removal process, significantly reducing potential hazardous waste disposal
costs associated with PFAS remediation projects, and is able to remove all
specified PFAS chemicals from water below EPA and state requirements.
Once the AEC system is installed, BioLargo will enter into an
ongoing service contract for the maintenance of the system as well as the removal
and disposal and destruction of the PFAS-laden waste.
John W. Clark, Jr. President of Lake Stockholm Systems, Inc.
said, “After an extensive review of the available technologies, including input
from our engineers and the state of New Jersey, we selected the BioLargo AEC to
ensure the drinking water in our community was free of harmful PFAS chemicals.
BioLargo’s solution will give us the peace of mind and guarantee that we can
meet remediation requirements, both today and in the future.”
BioLargo’s President and CEO Dennis P. Calvert commented,
“Lake Stockholm Systems recognized our technology as a more eco-friendly,
regulation-friendly, and cost-effective long-term solution for treating water
contaminated by PFAS. We believe the success of this project will play a big
role in attracting further municipal water treatment customers, many of whom
are still under the misconception that carbon filtration or ion exchange are
the only options for long-term PFAS remediation.”
Mr. Calvert continued, “Our technology reduces costs
customers pay to dispose of the harmful and hazardous waste produced by any
technology removing PFAS from water. For example, where a carbon system might
produce 80,000 pounds of hazardous spent carbon at the end of its life, we can
treat the same volume of water and produce less than five pounds of solid
waste. With CERCLA and RCRA regulations looming, which will require handling
PFAS-laden solid waste as hazardous materials, legacy technologies simply won’t
be able to compete with the AEC in this area.”
Learn more at www.bestPFAStreatment.com.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences
innovator and engineering services solution provider. Our core products address
PFAS contamination, achieve advanced water and wastewater treatment, control
odor and VOCs, improve air quality, enable energy-efficiency and safe on-site
energy storage, and control infections and infectious disease. Our approach is
to invent or acquire novel technologies, develop them into product offerings,
and extend their commercial reach through licensing and channel partnerships to
maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include without limitation those about
BioLargo’s (the “Company”) expectations regarding anticipated revenue; and
plans for future operations. These statements involve risks and uncertainties,
and actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include without
limitation: the effect of regional economic conditions on the Company’s
business, including effects on purchasing decisions by consumers and
businesses; the ability of the Company to compete in markets that are highly
competitive and subject to rapid technological change; the ability of the
Company to manage frequent introductions and transitions of products and
services, including delivering to the marketplace, and stimulating customer
demand for, new products, services, and technological innovations on a timely
basis; the dependency of the Company on the performance of distributors of the
Company’s products. More information on these risks and other potential factors
that could affect the Company’s business and financial results is included in
the Company’s filings with the SEC, including in the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of
Operations” sections of the Company’s most recently filed periodic reports on
Form 10-K and Form 10-Q and subsequent filings. The Company assumes no
obligation to update any forward-looking statements or information, which speak
as of their respective dates.
No comments:
Post a Comment